Enovis Cost of Goods Sold 2010-2024 | ENOV
Enovis cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
| Enovis Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $716 |
| 2022 | $694 |
| 2021 | $649 |
| 2020 | $517 |
| 2019 | $1,926 |
| 2018 | $1,464 |
| 2017 | $1,266 |
| 2016 | $2,193 |
| 2015 | $2,363 |
| 2014 | $3,146 |
| 2013 | $2,901 |
| 2012 | $2,762 |
| 2011 | $453 |
| 2010 | $351 |
| 2009 | $339 |
| Enovis Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-09-30 | $219 |
| 2024-06-30 | $236 |
| 2024-03-31 | $218 |
| 2023-12-31 | $191 |
| 2023-09-30 | $175 |
| 2023-06-30 | $180 |
| 2023-03-31 | $171 |
| 2022-12-31 | $177 |
| 2022-09-30 | $168 |
| 2022-06-30 | $179 |
| 2022-03-31 | $170 |
| 2021-12-31 | $-177 |
| 2021-09-30 | $162 |
| 2021-06-30 | $156 |
| 2021-03-31 | $508 |
| 2020-12-31 | $-792 |
| 2020-09-30 | $462 |
| 2020-06-30 | $379 |
| 2020-03-31 | $468 |
| 2019-12-31 | $493 |
| 2019-09-30 | $478 |
| 2019-06-30 | $533 |
| 2019-03-31 | $423 |
| 2018-12-31 | $132 |
| 2018-09-30 | $353 |
| 2018-06-30 | $369 |
| 2018-03-31 | $610 |
| 2017-12-31 | $-399 |
| 2017-09-30 | $581 |
| 2017-06-30 | $590 |
| 2017-03-31 | $494 |
| 2016-12-31 | $413 |
| 2016-09-30 | $528 |
| 2016-06-30 | $656 |
| 2016-03-31 | $596 |
| 2015-12-31 | $375 |
| 2015-09-30 | $673 |
| 2015-06-30 | $697 |
| 2015-03-31 | $617 |
| 2014-12-31 | $815 |
| 2014-09-30 | $791 |
| 2014-06-30 | $811 |
| 2014-03-31 | $729 |
| 2013-12-31 | $814 |
| 2013-09-30 | $694 |
| 2013-06-30 | $736 |
| 2013-03-31 | $656 |
| 2012-12-31 | $720 |
| 2012-09-30 | $666 |
| 2012-06-30 | $731 |
| 2012-03-31 | $645 |
| 2011-12-31 | $116 |
| 2011-09-30 | $110 |
| 2011-06-30 | $122 |
| 2011-03-31 | $105 |
| 2010-12-31 | $107 |
| 2010-09-30 | $85 |
| 2010-06-30 | $80 |
| 2010-03-31 | $78 |
| 2009-12-31 | $84 |
| 2009-09-30 | $82 |
| 2009-06-30 | $85 |
| 2009-03-31 | $88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.646B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.978B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.055B | 188.82 |
| Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
| Axonics (AXNX) | United States | $3.602B | 1762.00 |
| IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
| Privia Health (PRVA) | United States | $2.736B | 228.00 |
| Omnicell (OMCL) | United States | $2.263B | 74.03 |
| Azenta (AZTA) | United States | $2.242B | 127.33 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
| Schrodinger (SDGR) | United States | $1.422B | 0.00 |
| Phreesia (PHR) | United States | $1.252B | 0.00 |
| Standard BioTools (LAB) | United States | $0.830B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Talkspace (TALK) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
| Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| TruBridge (TBRG) | United States | $0.214B | 62.22 |
| P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.050B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| CareCloud (CCLD) | United States | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |